Mankind Pharma Ltd.

Eli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec

Abbreviated new drug application sponsor Mankind Pharma and originator AbbVie have moved jointly to dismiss pending paragraph IV patent-infringement litigation over Lumigan (bimatoprost) 0.01% ophthal

Join us for an audio catch-up on the major events in the biopharma industry over the past business week, as reported by Scrip ‘s global team, in this podcast version of Five Must-Know Things. This ep

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. OcuMension Signs Stock-for-Rights